Global Interventional Pulmonology Market Analysis Report 2024-2028: Robotic Bronchoscopy is Emerging as a Game Changer in the $5+ Billion Industry
April 16, 2024 07:32 ET
|
Research and Markets
Dublin, April 16, 2024 (GLOBE NEWSWIRE) -- The "Global Interventional Pulmonology Market: Insights & Forecast with Potential Impact of COVID-19 (2024-2028)" report has been added to ...
RS BioTherapeutics Selected for Presentation at American Thoracic Society’s 2024 Respiratory Innovation Summit
March 18, 2024 11:30 ET
|
RS BioTherapeutics
RS BioTherapeutics is pleased to announce that its submission has been selected for a poster presentation at the 2024 Respiratory Innovation Summit
Chronic Disease Management Market revenue to reach USD 27 Billion by 2035, says Research Nester
March 13, 2024 07:30 ET
|
Research Nester
New York, March 13, 2024 (GLOBE NEWSWIRE) -- The global chronic disease management market size is projected to grow at a CAGR of over ~13% from 2023 to 2035. The market is expected to garner a...
Monaghan Medical Corporation Attains ISO 14001 Certification for Environmental Management Excellence
February 27, 2024 07:00 ET
|
Monaghan Medical Corporation
Monaghan Medical Corporation is proud to have achieved ISO 14001 certification
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of COPD with Type 2 Inflammation
February 23, 2024 01:00 ET
|
Regeneron Pharmaceuticals, Inc.
Priority Review granted based on positive results from two Phase 3 trials; if approved, Dupixent would be the only biologic therapy for COPD and the first new treatment approach for this disease in...
RS BioTherapeutics Creates Therapeutic Expert Council to Provide Guidance on Development of First-in-Class Agent Focused on Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis
February 21, 2024 09:52 ET
|
RS BioTherapeutics
RS BioTherapeutics is pleased to announce the formation of its Therapeutic Expert Council (TEC).
Pulmonary Drug Delivery Devices Market revenue to hit USD 105 Billion by 2035, says Research Nester
January 31, 2024 05:30 ET
|
Research Nester
New York, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The global pulmonary drug delivery devices market size is predicted to expand at ~7% CAGR between 2023 and 2035. The market is projected to garner a...
Study Estimates a 23% Increase in COPD by 2050, Representing 600 Million Patients Globally
December 07, 2023 15:34 ET
|
ResMed Inc.
New study shows Chronic Obstructive Pulmonary Disease (COPD) increasing globally through 2050, with 47% growth among women.
Pneumagen Announces Successful Clinical Proof of Concept for its Broad-Spectrum Antiviral Neumifil in Phase 2 Influenza Human Challenge Study
October 02, 2023 04:00 ET
|
Pneumagen Ltd
Study achieves primary & secondary endpoints in a randomised, placebo-controlled challenge studyNeumifil delivers a statistically significant reduction in both symptomatic infection rate &...
Chronic Obstructive Pulmonary Disease Market to Witness Upsurge in Growth During the Forecast Period (2023–2032), Assesses DelveInsight | Key Companies - Genentech, GlaxoSmithKline, Regeneron, Sanofi, AstraZeneca, Mereo, Inmunotek
September 25, 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Chronic Obstructive Pulmonary Disease Market to Witness Upsurge in Growth During the Forecast Period (2023–2032), Assesses DelveInsight | Key...